Search results
Why Moderna Stock Rallied Today
Motley Fool· 2 years agoShares of Moderna (NASDAQ: MRNA) jumped 8.4% on Friday after rival drugmaker Pfizer (NYSE: PFE) said it intends to drastically increase the price of its...
Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?
Motley Fool via Yahoo Finance· 5 months agoOn Dec. 14, Moderna (NASDAQ: MRNA) and Merck (NYSE: MRK) jointly reported some great news for...
Stock Market Climbs As Services Sector Jumps; PayPal And Moderna Lead On Earnings
Investor's Business Daily· 2 years agoThe stock market climbed Wednesday as the services sector rallied on fresh economic data. Fintech...
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
Motley Fool· 8 months agoThe Food and Drug Administration (FDA) just approved the updated Omicron-adapted COVID-19 booster...
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine
Motley Fool· 8 months agoOnce a relatively unknown biotech company, Moderna (NASDAQ: MRNA) became a household name when it...
Better Recovery Story Buy: Pfizer vs Moderna
Motley Fool via Yahoo Finance· 2 months agoA few years ago, both Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were flying high: from an earnings and share performance perspective. They each sold...
Better Bull Market Buy: Pfizer vs. Moderna
Motley Fool via Yahoo Finance· 4 months agoCOVID-19 has been especially rough for Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) investors over the last couple of years. Shares of both drugmakers...
Stock Market Trades Mixed After Jobs Report; Health Care Dominates, Led By Humana And Moderna
Investor's Business Daily· 2 years agoAfter seesaw trading, the stock market closed mixed Friday after the monthly employment report...
Could This News from Pfizer Equal Billions for Moderna?
Motley Fool· 2 years agoPfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) both have generated billions of dollars of revenue...
3 No-Brainer Healthcare Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 5 months agoEarlier in the pandemic, coronavirus products boosted the revenue and the stock prices of companies selling those products. But these days, those...
